These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20227436)

  • 21. Dehydroepiandrosterone--a neurosteroid.
    Friess E; Schiffelholz T; Steckler T; Steiger A
    Eur J Clin Invest; 2000 Dec; 30 Suppl 3():46-50. PubMed ID: 11281367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-D-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms.
    Kurata K; Takebayashi M; Morinobu S; Yamawaki S
    J Pharmacol Exp Ther; 2004 Oct; 311(1):237-45. PubMed ID: 15175425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neurosteroids dehydroepiandrosterone sulfate and pregnenolone sulfate inhibit the UNC-49 GABA receptor through a common set of residues.
    Twede V; Tartaglia AL; Covey DF; Bamber BA
    Mol Pharmacol; 2007 Nov; 72(5):1322-9. PubMed ID: 17715402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DHEA(S): the fountain of youth.
    Leowattana W
    J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S605-12. PubMed ID: 11853289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection.
    Maurice T; Grégoire C; Espallergues J
    Pharmacol Biochem Behav; 2006 Aug; 84(4):581-97. PubMed ID: 16945406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dehydroepiandrosterone and Addiction.
    Yadid G; Ahdoot-Levi H; Bareli T; Maayan R; Weizman A
    Vitam Horm; 2018; 108():385-412. PubMed ID: 30029736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Focus on dehydroepiandrosterone (DHEA)].
    Meyer P; Meier CA
    Rev Med Suisse; 2005 Feb; 1(6):415-8. PubMed ID: 15786645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control.
    Feil J; Sheppard D; Fitzgerald PB; Yücel M; Lubman DI; Bradshaw JL
    Neurosci Biobehav Rev; 2010 Nov; 35(2):248-75. PubMed ID: 20223263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exploratory pilot investigation of neurosteroids and self-reported pain in female Iraq/Afghanistan-era Veterans.
    Naylor JC; Kilts JD; Strauss JL; Szabo ST; Dunn CE; Wagner HR; Hamer RM; Shampine LJ; Zanga JR; Marx CE;
    J Rehabil Res Dev; 2016; 53(4):499-510. PubMed ID: 27533747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.
    Iancu I; Tchernihovsky E; Maayan R; Poreh A; Dannon P; Kotler M; Weizman A; Strous RD
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):541-5. PubMed ID: 17346944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dehydroepiandrosterone sulphate: action and mechanism in the brain.
    Dong Y; Zheng P
    J Neuroendocrinol; 2012 Jan; 24(1):215-24. PubMed ID: 22145821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors.
    Takebayashi M; Hayashi T; Su TP
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S208-13. PubMed ID: 15547787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer's Disease.
    Strac DS; Konjevod M; Perkovic MN; Tudor L; Erjavec GN; Pivac N
    Curr Alzheimer Res; 2020; 17(2):141-157. PubMed ID: 32183671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dehydroepiandrosterone, "the youth hormone", in the light of recent findings].
    Hampl R; Stárka L
    Cas Lek Cesk; 1998 Jan; 137(1):8-12. PubMed ID: 9511270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurosteroids: a novel function of the brain.
    Baulieu EE
    Psychoneuroendocrinology; 1998 Nov; 23(8):963-87. PubMed ID: 9924747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia.
    Laufer N; Maayan R; Hermesh H; Marom S; Gilad R; Strous R; Weizman A
    Psychiatry Res; 2005 Nov; 137(1-2):131-6. PubMed ID: 16226317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurosteroids: beginning of the story.
    Baulieu EE; Robel P; Schumacher M
    Int Rev Neurobiol; 2001; 46():1-32. PubMed ID: 11599297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prefrontal cortex plasticity mechanisms in drug seeking and relapse.
    Van den Oever MC; Spijker S; Smit AB; De Vries TJ
    Neurosci Biobehav Rev; 2010 Nov; 35(2):276-84. PubMed ID: 19932711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dehydroepiandrosterone and its sulfate metabolite on neuronal cell viability in culture.
    Gil-ad I; Shtaif B; Eshet R; Maayan R; Rehavi M; Weizman A
    Isr Med Assoc J; 2001 Sep; 3(9):639-43. PubMed ID: 11574977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence.
    Genazzani AR; Pluchino N
    Climacteric; 2010 Aug; 13(4):314-6. PubMed ID: 20540592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.